Has Hank Yang received payments from drug or device companies?

Yes. Drug and device makers reported $8,550 in general payments to Hank Yang across 159 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Hank Yang did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Hank Yang come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Hank Yang

Obstetrics & Gynecology · Clovis, CANPI 1356429831

Payments from drug & device makers

$8,550in general payments, 2019–2025

Across 159 payments — averaging $53.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AstraZeneca$4K
Bristol Myers Squibb$2K
GSK$359
Takeda Pharmaceuticals U.S.A., Inc.$318
Eisai Inc.$300
Hologic Sales And Service, LLC$167
plus $2K from 29 others

What the payments were for

Consulting fees$4,49553%
Food & beverage$4,02347%
Education$330%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AstraZeneca	36	$3,568
Bristol Myers Squibb	4	$1,768
GSK	8	$359
Takeda Pharmaceuticals U.S.A., Inc.	11	$318
Eisai Inc.	15	$300
Hologic Sales And Service, LLC	2	$167
Beigene USA, Inc.	6	$161
Pfizer	7	$146
Johnson & Johnson	4	$137
Pharmacyclics LLC, An Abbvie Company	1	$125
Incyte Corporation	5	$116
Stemline Therapeutics Inc.	3	$113
Ipsen Biopharmaceuticals, Inc	5	$111
Puma Biotechnology, Inc.	4	$109
Beone Medicines USA, Inc.	6	$108
AVEO Pharmaceuticals, Inc.	4	$102
Array Biopharma Inc	4	$84
Lilly USA, LLC	4	$79
Syndax Pharmaceuticals, Inc.	3	$71
Morphosys, US Inc.	3	$67
Jazz Pharmaceuticals Inc.	2	$58
Genentech USA, Inc.	2	$51
Clovis Oncology, Inc.	2	$48
Rigel Pharmaceuticals, Inc.	2	$45
Mirati Therapeutics, Inc.	2	$45
Gilead	2	$44
EMD Serono, Inc.	2	$40
ADC Therapeutics America, Inc.	2	$39
Verastem, Inc.	2	$34
Genmab U.S., Inc.	1	$30
Taiho Oncology, Inc.	1	$25
Karyopharm Therapeutics Inc.	1	$25
Novocure Inc.	1	$24
Daiichi Sankyo Inc.	1	$19
Pharmaand GmbH	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,550 in reported general payments places this provider in the 90th percentile of 3,784 obstetrics & gynecology providers in California.

See all obstetrics & gynecology providers in California →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Estradiol	38	$1,136
Triamcinolone Acetonide	13	$153
Lidocaine	11	$145
Medroxyprogesterone Acetate	12	$143

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Clovis

Peyman BanooniBeverly Hills$9.2M
Vellore BhupathyWhittier$4.3M
Edwin RamirezOxnard$3.5M
Nam TranSan Francisco$3M
Dmitriy RomanenkoSouth Gate$2.7M
Anita NelsonTorrance$2.1M
Oleg BessLos Angeles$1.7M
Rovena ReaganSan Diego$1.7M
Dana Shippdel Mar$1.7M
Vanessa JacobySan Francisco$1.3M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →